XML 83 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 19 - Operations and Industry Segments and Geographic Areas
12 Months Ended
Sep. 29, 2012
Segment Reporting Disclosure [Text Block]
19.  OPERATIONS AND INDUSTRY SEGMENTS AND GEOGRAPHIC AREAS

For management and reporting purposes, we divide our business into two segments:  medical and custom products.  This industry segment information corresponds to the markets in the United States and Canada for which we manufacture and distribute our various products.  The following table summarizes certain information on industry segments:

   
2012
   
2011
   
2010
 
Net sales:
                 
United States
  $ 67,981,932     $ 50,721,211     $ 50,632,653  
Canada
    7,920,424       1,275,494       1,535,861  
Other
    244,067       581,667       187,148  
Total
  $ 76,146,423     $ 52,578,372     $ 52,355,662  
                         
Net sales:
                       
Medical
  $ 46,452,008     $ 34,741,164     $ 35,572,689  
Custom products
    29,694,415       17,837,208       16,782,973  
Total
  $ 76,146,423     $ 52,578,372     $ 52,355,662  
                         
Operating profit:
                       
Medical
  $ 5,349,910     $ 4,666,538     $ 5,742,600  
Custom products
    2,797,465       1,518,916       1,628,106  
Total
    8,147,375       6,185,454       7,370,706  
                         
Corporate expense
    (637,310 )     (710,281 )     (636,685 )
Other (expense) income
    (44,092 )     18,893       52,194  
Income from continuing operations before income taxes
  $ 7,465,973     $ 5,494,066     $ 6,786,215  
                         
Identifiable assets:
                       
Medical
  $ 23,814,524     $ 15,209,839     $ 14,439,795  
Custom products
    9,030,782       7,097,568       6,016,135  
Corporate
    4,802,460       8,288,593       6,756,258  
    $ 37,647,766     $ 30,596,000     $ 27,212,188  

Depreciation and amortization expenses:
                 
Operating:
                 
Medical
  $ 872,909     $ 529,050     $ 533,184  
Custom products
    336,114       280,381       279,636  
Corporate
    303       265       471  
    $ 1,209,326     $ 809,696     $ 813,291  
                         
Capital expenditures:
                       
Medical
  $ 477,658     $ 159,527     $ 252,985  
Custom products
    206,669       31,682       17,591  
    $ 684,327     $ 191,209     $ 270,576  

Total sales by industry segment include sales from unaffiliated customers as reported in our statements of income.  In calculating operating profit, non-allocable general corporate expenses, interest expense, other income and income taxes are not included, but certain corporate operating expenses incurred for the benefit of all segments are included on an allocated basis.

Identifiable assets are those assets that are used in the operations of each segment on an allocated basis.  Amounts shown for corporate assets consist primarily of cash, marketable securities and cash surrender value of life insurance.

Included in the consolidated balance sheet at September 29, 2012, are the net assets of Span Canada’s operations located in a single facility in Canada which total approximately $12,000,000.

We have several customers whose sales represent significant portions of sales in their respective business segments.  In the medical segment, sales to the top two distributors represented 21% of net medical sales in 2012, 28% in 2011 and 28% in 2010.  In the custom products segment, sales to one customer accounted for 88% of net custom products sales in 2012, 83% in 2011, and 82% in 2010.